OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: University of South Florida

4 Projects | 3 Researchers | $475,612 Invested

2011

University of South Florida

Chad Dickey, PhD

A Novel Enantiomeric Diarylheptanoid Derived from Myrica cerifera as an Anti-Tau Therapeutic

  • Funding Amount: $150,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2008

University of South Florida

Juan Sanchez-Ramos

Efficacy and Safety of Filgastrim (Neupogen®) as a Pro-cognitive Agent for Alzheimer's Disease

  • Funding Amount: $180,000
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Status: Closed

2006

University of South Florida

Juan Sanchez-Ramos

Bone Marrow-Mobilizing Agents for Alzheimer's Disease

  • Funding Amount: $70,802
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2005

University of South Florida

Jun Tan, PhD

Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces amyloidosis in Alzheimer’s transgenic mice

  • Funding Amount: $74,810
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed